Catherine Morrissey

477 total citations
11 papers, 229 citations indexed

About

Catherine Morrissey is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Catherine Morrissey has authored 11 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Oncology. Recurrent topics in Catherine Morrissey's work include Hematopoietic Stem Cell Transplantation (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Herpesvirus Infections and Treatments (2 papers). Catherine Morrissey is often cited by papers focused on Hematopoietic Stem Cell Transplantation (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Herpesvirus Infections and Treatments (2 papers). Catherine Morrissey collaborates with scholars based in Australia, United States and United Kingdom. Catherine Morrissey's co-authors include Anton Y. Peleg, Andrew Spencer, Allen Cheng, Sabine Zöchbauer‐Müller, Farida Latif, Sofia Honorio, Ashraf Dallol, Angelo Agathanggelou, Kwun M. Fong and John D. Minna and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and Oncogene.

In The Last Decade

Catherine Morrissey

11 papers receiving 227 citations

Peers

Catherine Morrissey
Catherine Morrissey
Citations per year, relative to Catherine Morrissey Catherine Morrissey (= 1×) peers Federica Lessi

Countries citing papers authored by Catherine Morrissey

Since Specialization
Citations

This map shows the geographic impact of Catherine Morrissey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Morrissey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Morrissey more than expected).

Fields of papers citing papers by Catherine Morrissey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Morrissey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Morrissey. The network helps show where Catherine Morrissey may publish in the future.

Co-authorship network of co-authors of Catherine Morrissey

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Morrissey. A scholar is included among the top collaborators of Catherine Morrissey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Morrissey. Catherine Morrissey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Curtis, David J., Sushrut Patil, John Reynolds, et al.. (2025). Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin. New England Journal of Medicine. 393(3). 243–254. 1 indexed citations
2.
Gardiner, Bradley J., Sue J. Lee, Gregory I. Snell, et al.. (2022). Real-world experience of Quantiferon-CMV directed prophylaxis in lung transplant recipients. The Journal of Heart and Lung Transplantation. 41(9). 1258–1267. 14 indexed citations
3.
Griffin, David, Gopal Basu, Paul Gow, et al.. (2021). Human immunodeficiency virus and solid organ transplantation: a 15‐year retrospective audit at a tertiary Australian transplant centre. Internal Medicine Journal. 52(10). 1780–1790. 3 indexed citations
4.
Cairns, Kelly A., Victoria Hall, Geneviève Martin, et al.. (2020). Treatment of invasive IMP‐4Enterobacter cloacaeinfection in transplant recipients using ceftazidime/avibactam with aztreonam: A case series and literature review. Transplant Infectious Disease. 23(2). e13510–e13510. 23 indexed citations
5.
Stewart, James, Anna Kalff, Shaun Fleming, et al.. (2020). A 40-Year-Old Man With Persistent Febrile Neutropenia and Subsequent Rash. Clinical Infectious Diseases. 71(12). 3260–3262. 1 indexed citations
6.
Morrissey, Catherine. (2019). Unraveling the relationship between rejection and infection. The Journal of Heart and Lung Transplantation. 38(11). 1233–1234. 1 indexed citations
7.
Ffrench, Rosemary, Maya Korem, David J. Curtis, et al.. (2018). Contemporary analysis of functional immune recovery to opportunistic and vaccine‐preventable infections after allogeneic haemopoietic stem cell transplantation. Clinical & Translational Immunology. 7(10). e1040–e1040. 4 indexed citations
8.
Smibert, Olivia, Heather L. Wilson, Shanti Narayanasamy, et al.. (2017). Donor-Derived Mycoplasma hominis and an Apparent Cluster of M. hominis Cases in Solid Organ Transplant Recipients. Clinical Infectious Diseases. 65(9). 1504–1508. 27 indexed citations
9.
Yong, Michelle K., Paul Cameron, Monica A. Slavin, et al.. (2017). Low T-Cell Responses to Mitogen Stimulation Predicts Poor Survival in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. Frontiers in Immunology. 8. 1506–1506. 15 indexed citations
10.
Morrissey, Catherine, et al.. (2014). Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9‐year period. Transplant Infectious Disease. 16(6). 887–896. 56 indexed citations
11.
Agathanggelou, Angelo, Ashraf Dallol, Sabine Zöchbauer‐Müller, et al.. (2003). Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Oncogene. 22(10). 1580–1588. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026